Novel Heterodimers that Function as Acetylcholinesterase Inhibitors and NMDA Receptor Antagonists
Novel heterodimers of tetrahydroacridines and tetrahydroquinolinones are disclosed. The heterodimers are capable of acting as both acetylcholinesterase inhibitors and N-methyl-D-aspartate (NMDA) receptor antagonists. The heterodimers may be used to improve cognitive defects via treatment or prevention in both humans and non-humans.
Countries or Regions:
USA, UK, Hong Kong, China
Invention Code:
TTC.PA.1066
Contact Us:
okt@ust.hk
Authors:
Key Features:
Specification:
Category:
TAP - Neuroscience
Reference:
Contact Us:
Download (0)
No file is available now.
You would be able to download the files marked with an asterisk '*' only after logging in to your account and completing the purchase of the product license.